In Q2, it brought in $11.3 billion in sales, 36% higher than a year prior, and it cranked up its annual revenue guidance for ...

CVS Health executives and hedge fund Glenview Capital Management were reportedly planning to meet today to discuss a shakeup ...

The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we ...

After the terrible year CVS Health has had, it shouldn’t come as a surprise that the struggling healthcare company is looking ...

Guardian Pharmacy's shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million ...

RBC believes that TNDM’s earnings growth and increasing profitability make it an attractive investment opportunity. Related Articles This pharma stock offers an attractive risk-reward says RBC ...

and JSW Steel Ltd. Sudarshan Pharma’s shares rose nearly 2% after announcing a 1:10 stock split. The company is expanding its operations through acquisitions and plans to boost production ...

One thing Santa won't be bringing this year is a new supply of the type 2 diabetes drug, Ozempic! As the supply shortens it's prices are soaring.

Eli Lilly (NYSE: LLY) is already a top pharmaceutical stock, and there are no signs that ... Even for a major pharma business, it might seem to be a bit early in these drugs' commercial lives ...